These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 21992114)

  • 1. The structural basis for homotropic and heterotropic cooperativity of midazolam metabolism by human cytochrome P450 3A4.
    Roberts AG; Yang J; Halpert JR; Nelson SD; Thummel KT; Atkins WM
    Biochemistry; 2011 Dec; 50(50):10804-18. PubMed ID: 21992114
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for regiospecific midazolam oxidation by human cytochrome P450 3A4.
    Sevrioukova IF; Poulos TL
    Proc Natl Acad Sci U S A; 2017 Jan; 114(3):486-491. PubMed ID: 28031486
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Homotropic Cooperativity of Midazolam Metabolism by Cytochrome P450 3A4: Insight from Computational Studies.
    Li J; Chen Y; Tang Y; Li W; Tu Y
    J Chem Inf Model; 2021 May; 61(5):2418-2426. PubMed ID: 33884878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Heterotropic Allosteric Modulation on the Time-Dependent Inhibition of Cytochrome P450 3A4.
    Rougée LRA; Bedwell DW; Hansen K; Abraham TL; Hall SD
    Drug Metab Dispos; 2023 Oct; 51(10):1372-1380. PubMed ID: 37524542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midazolam as a Probe for Drug-Drug Interactions Mediated by CYP3A4: Homotropic Allosteric Mechanism of Site-Specific Hydroxylation.
    Denisov IG; Grinkova YV; Camp T; McLean MA; Sligar SG
    Biochemistry; 2021 Jun; 60(21):1670-1681. PubMed ID: 34015213
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cooperative binding of midazolam with testosterone and alpha-naphthoflavone within the CYP3A4 active site: a NMR T1 paramagnetic relaxation study.
    Cameron MD; Wen B; Allen KE; Roberts AG; Schuman JT; Campbell AP; Kunze KL; Nelson SD
    Biochemistry; 2005 Nov; 44(43):14143-51. PubMed ID: 16245930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concurrent cooperativity and substrate inhibition in the epoxidation of carbamazepine by cytochrome P450 3A4 active site mutants inspired by molecular dynamics simulations.
    Müller CS; Knehans T; Davydov DR; Bounds PL; von Mandach U; Halpert JR; Caflisch A; Koppenol WH
    Biochemistry; 2015 Jan; 54(3):711-21. PubMed ID: 25545162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Insights into the Heterotropic Allosteric Mechanism in Cytochrome P450 3A4-Mediated Midazolam Metabolism.
    Fu T; Zhang H; Zheng Q
    J Chem Inf Model; 2022 Nov; 62(22):5762-5770. PubMed ID: 36342224
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamics and Location of the Allosteric Midazolam Site in Cytochrome P4503A4 in Lipid Nanodiscs.
    Redhair M; Hackett JC; Pelletier RD; Atkins WM
    Biochemistry; 2020 Feb; 59(6):766-779. PubMed ID: 31961139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition and kinetics of cytochrome P4503A activity in microsomes from rat, human, and cdna-expressed human cytochrome P450.
    Ghosal A; Satoh H; Thomas PE; Bush E; Moore D
    Drug Metab Dispos; 1996 Sep; 24(9):940-7. PubMed ID: 8886602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Midazolam as a Probe for Heterotropic Drug-Drug Interactions Mediated by CYP3A4.
    Denisov IG; Grinkova YV; McLean MA; Camp T; Sligar SG
    Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heterotropic activation of the midazolam hydroxylase activity of CYP3A by a positive allosteric modulator of mGlu5: in vitro to in vivo translation and potential impact on clinically relevant drug-drug interactions.
    Blobaum AL; Bridges TM; Byers FW; Turlington ML; Mattmann ME; Morrison RD; Mackie C; Lavreysen H; Bartolomé JM; Macdonald GJ; Steckler T; Jones CK; Niswender CM; Conn PJ; Lindsley CW; Stauffer SR; Daniels JS
    Drug Metab Dispos; 2013 Dec; 41(12):2066-75. PubMed ID: 24003250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential effect of Shenmai injection, a herbal preparation, on the cytochrome P450 3A-mediated 1'-hydroxylation and 4-hydroxylation of midazolam.
    Xia C; Sun J; Wang G; Shang L; Zhang X; Zhang R; Wang X; Hao H; Xie L
    Chem Biol Interact; 2009 Aug; 180(3):440-8. PubMed ID: 19557931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing the role of residue Phe108 of cytochrome P450 3A4 in allosteric effects of midazolam metabolism.
    Fu T; Zhang H; Zheng Q
    Phys Chem Chem Phys; 2024 Mar; 26(11):8807-8814. PubMed ID: 38421040
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes.
    Quintieri L; Palatini P; Nassi A; Ruzza P; Floreani M
    Biochem Pharmacol; 2008 Mar; 75(6):1426-37. PubMed ID: 18191104
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterotropic cooperativity of cytochrome P450 3A4 and potential drug-drug interactions.
    Tang W; Stearns RA
    Curr Drug Metab; 2001 Jun; 2(2):185-98. PubMed ID: 11469725
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Midazolam oxidation by cytochrome P450 3A4 and active-site mutants: an evaluation of multiple binding sites and of the metabolic pathway that leads to enzyme inactivation.
    Khan KK; He YQ; Domanski TL; Halpert JR
    Mol Pharmacol; 2002 Mar; 61(3):495-506. PubMed ID: 11854429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence of CYP3A allosterism in vivo: analysis of interaction between fluconazole and midazolam.
    Yang J; Atkins WM; Isoherranen N; Paine MF; Thummel KE
    Clin Pharmacol Ther; 2012 Mar; 91(3):442-9. PubMed ID: 22048224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Investigation of the molecular and mechanistic basis for the regioselective metabolism of midazolam by cytochrome P450 3A4.
    Fu T; Zheng Q; Zhang H
    Phys Chem Chem Phys; 2022 Apr; 24(14):8104-8112. PubMed ID: 35319551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Defective activity of recombinant cytochromes P450 3A4.2 and 3A4.16 in oxidation of midazolam, nifedipine, and testosterone.
    Miyazaki M; Nakamura K; Fujita Y; Guengerich FP; Horiuchi R; Yamamoto K
    Drug Metab Dispos; 2008 Nov; 36(11):2287-91. PubMed ID: 18669585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.